Title: A bill to require regulatory review of pharmaceutical products from Chinese entities, and for other purposes. Description: A bill to require regulatory review of pharmaceutical products from Chinese entities, and for other purposes.
A bill to require regulatory review of pharmaceutical products from Chinese entities, and for other purposes.
Introduced on 4/16/26